KOY.F Kobayashi Pharmaceutical Co. Ltd

Consumer Defensive Personal Care Products Frankfurt Exchange
38.80 EUR
Close of Nov 13, 2026
26.83 40.40
Market cap
EUR 2.88B
P/E
114.1x
P/B
2.38x
ROE
4.9%
Dividend yield
1.51%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is KOY.F undervalued?

Graham number

The Graham number of Kobayashi Pharmaceutical Co. Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kobayashi Pharmaceutical Co. Ltd fundamental analysis

No fundamental analysis for Kobayashi Pharmaceutical Co. Ltd yet.

Kobayashi Pharmaceutical Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kobayashi Pharmaceutical Co. Ltd

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabo…

Full company profile